Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genentech Breaks Ground on Manufacturing Site in Holly Springs, NC | Contract Pharma
Breaking News

Genentech Breaks Ground on Manufacturing Site in Holly Springs, NC

The new facility will increase Roche’s manufacturing capacity and enhance supply chain resilience.

The groundbreaking ceremony.

Genentech, a member of the Roche Group, has broken ground on its newest U.S. manufacturing site in Holly Springs, North Carolina—its first manufacturing facility on the East Coast.

Genentech’s initial investment in North Carolina is estimated at more than $700 million and is part of Roche’s $50 billion commitment to invest in U.S. manufacturing infrastructure and R&D. The 65,000 m² facility is strategically designed to support production of the company’s future portfolio of metabolic medicines, including next-generation treatments for obesity.

Roche Group CEO Thomas Schinecker said, “I am proud to break ground on our new state-of-the-art manufacturing facility in North Carolina, which will support the production of our next-generation obesity treatments.”

Designed for high-volume, efficient, and sustainable production, the new facility will increase Roche’s manufacturing capacity and enhance supply chain resilience. It complements Roche’s manufacturing sites around the world, including in Europe and Switzerland.

The new facility is expected to be completed and operational by 2029, incorporating modern biomanufacturing technologies, as well as advanced automation and digital capabilities. The 400,000 m² lot includes space for future expansion. It will create more than 1,900 jobs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters